pH-sensitive polymeric nanoparticles to improve oral bioavailability of peptide/protein drugs and poorly water-soluble drugs.

Xue-Qing Wang,Qiang Zhang

DOI: https://doi.org/10.1016/j.ejpb.2012.07.014

IF: 5.589

2012-01-01

European Journal of Pharmaceutics and Biopharmaceutics

Abstract:Drug release mechanisms from conventional and pH-sensitive nanoparticles. (A) Release from conventional nanoparticles by diffusion; (B) release from pH-sensitive nanoparticles after the materials dissolution at specific pH; (C) release from pH-sensitive nanomatrix by two steps, pH sensitive polymers dissolve first, a small part of drug released; then nano-porous silica exposed and drug embedded in the nano-pores diffused out of the pores; (D) release from pH-sensitive nanoparticles after the materials swelling at specific pH; and (E) release from pH-sensitive nanoparticles as the co-effect of dissolution and swelling of the materials at specific pH.